Kalaris Therapeutics, Inc.

Siren, L.L.C. KLRS
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/14/2026
Shares
435,798
Value ($000)
2,515
Weight
0.1%
2025 Q1 - 2026 Q1 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).